204 related articles for article (PubMed ID: 34228537)
21. Isolation and characterization of herpes simplex virus type 1 resistant to aminothiazolylphenyl-based inhibitors of the viral helicase-primase.
Liuzzi M; Kibler P; Bousquet C; Harji F; Bolger G; Garneau M; Lapeyre N; McCollum RS; Faucher AM; Simoneau B; Cordingley MG
Antiviral Res; 2004 Dec; 64(3):161-70. PubMed ID: 15550269
[TBL] [Abstract][Full Text] [Related]
22. The UL5 and UL52 subunits of the herpes simplex virus type 1 helicase-primase subcomplex exhibit a complex interdependence for DNA binding.
Biswas N; Weller SK
J Biol Chem; 2001 May; 276(20):17610-9. PubMed ID: 11278618
[TBL] [Abstract][Full Text] [Related]
23. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
24. The two helicases of herpes simplex virus type 1 (HSV-1).
Chattopadhyay S; Chen Y; Weller SK
Front Biosci; 2006 Sep; 11():2213-23. PubMed ID: 16720308
[TBL] [Abstract][Full Text] [Related]
25. Role of the herpes simplex virus helicase-primase complex during adeno-associated virus DNA replication.
Slanina H; Weger S; Stow ND; Kuhrs A; Heilbronn R
J Virol; 2006 Jun; 80(11):5241-50. PubMed ID: 16699004
[TBL] [Abstract][Full Text] [Related]
26. Herpes simplex virus-1 helicase-primase: roles of each subunit in DNA binding and phosphodiester bond formation.
Cavanaugh NA; Ramirez-Aguilar KA; Urban M; Kuchta RD
Biochemistry; 2009 Nov; 48(43):10199-207. PubMed ID: 19788334
[TBL] [Abstract][Full Text] [Related]
27. Identification of the primase active site of the herpes simplex virus type 1 helicase-primase.
Dracheva S; Koonin EV; Crute JJ
J Biol Chem; 1995 Jun; 270(23):14148-53. PubMed ID: 7775476
[TBL] [Abstract][Full Text] [Related]
28. One-step column purification of herpes simplex virus 1 helicase-primase subcomplex using C-terminally his-tagged UL5 subunit.
Schreiner U; Theune M; Althof F; Kehm E; Knopf CW
Virus Genes; 2009 Aug; 39(1):19-29. PubMed ID: 19396588
[TBL] [Abstract][Full Text] [Related]
29. UL23, UL30, and UL5 characterization of HSV1 clinical strains isolated from hematology department patients.
Labrunie T; Ducastelle S; Domenech C; Ader F; Morfin F; Frobert E
Antiviral Res; 2019 Aug; 168():114-120. PubMed ID: 31152759
[TBL] [Abstract][Full Text] [Related]
30. Single amino acid substitutions in the HSV-1 helicase protein that confer resistance to the helicase-primase inhibitor BAY 57-1293 are associated with increased or decreased virus growth characteristics in tissue culture.
Biswas S; Jennens L; Field HJ
Arch Virol; 2007; 152(8):1489-500. PubMed ID: 17404685
[TBL] [Abstract][Full Text] [Related]
31. Herpes simplex virus type 1 helicase-primase: DNA binding and consequent protein oligomerization and primase activation.
Chen Y; Bai P; Mackay S; Korza G; Carson JH; Kuchta RD; Weller SK
J Virol; 2011 Jan; 85(2):968-78. PubMed ID: 21068246
[TBL] [Abstract][Full Text] [Related]
32. Antiviral efficacy of the helicase-primase inhibitor amenamevir in murine models of severe herpesvirus infection.
Katsumata K; Chono K; Suzuki H
Biochem Pharmacol; 2018 Dec; 158():201-206. PubMed ID: 30365949
[TBL] [Abstract][Full Text] [Related]
33. The UL8 subunit of the helicase-primase complex of herpes simplex virus promotes DNA annealing and has a high affinity for replication forks.
Bermek O; Weller SK; Griffith JD
J Biol Chem; 2017 Sep; 292(38):15611-15621. PubMed ID: 28743747
[TBL] [Abstract][Full Text] [Related]
34. Helicase-primase inhibitor amenamevir for herpesvirus infection: Towards practical application for treating herpes zoster.
Shiraki K
Drugs Today (Barc); 2017 Nov; 53(11):573-584. PubMed ID: 29451274
[TBL] [Abstract][Full Text] [Related]
35. Mismatch primer-based PCR reveals that helicase-primase inhibitor resistance mutations pre-exist in herpes simplex virus type 1 clinical isolates and are not induced during incubation with the inhibitor.
Sukla S; Biswas S; Birkmann A; Lischka P; Zimmermann H; Field HJ
J Antimicrob Chemother; 2010 Jul; 65(7):1347-52. PubMed ID: 20453068
[TBL] [Abstract][Full Text] [Related]
36. Two-hybrid analysis of the interaction between the UL52 and UL8 subunits of the herpes simplex virus type 1 helicase-primase.
Constantin N; Dodson MS
J Gen Virol; 1999 Sep; 80 ( Pt 9)():2411-2415. PubMed ID: 10501495
[TBL] [Abstract][Full Text] [Related]
37. Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster.
Shiraki K; Yasumoto S; Toyama N; Fukuda H
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452412
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of amenamevir on acute herpetic pain and postherpetic neuralgia in mice infected with herpes simplex virus-1.
Ueda Y; Uta D; Tanbo S; Kawabata A; Kanayama S; Osaki M; Nozawa N; Matsumoto T; Andoh T
J Dermatol Sci; 2020 Apr; 98(1):50-57. PubMed ID: 32284168
[TBL] [Abstract][Full Text] [Related]
39. Biochemical analyses of mutations in the HSV-1 helicase-primase that alter ATP hydrolysis, DNA unwinding, and coupling between hydrolysis and unwinding.
Graves-Woodward KL; Gottlieb J; Challberg MD; Weller SK
J Biol Chem; 1997 Feb; 272(7):4623-30. PubMed ID: 9020191
[TBL] [Abstract][Full Text] [Related]
40. Effects of therapy using a helicase-primase inhibitor (HPI) in mice infected with deliberate mixtures of wild-type HSV-1 and an HPI-resistant UL5 mutant.
Sukla S; Biswas S; Birkmann A; Lischka P; Ruebsamen-Schaeff H; Zimmermann H; Field HJ
Antiviral Res; 2010 Jul; 87(1):67-73. PubMed ID: 20420855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
